Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.

<h4>Background</h4>Protein aggregation plays a major role in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease. However, direct real-time imaging of protein aggregation, including oligomerization and fibrillization, has never been achieved. Here we demonst...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiyotaka Tokuraku, Meg Marquardt, Tsuneya Ikezu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-12-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0008492&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236435175571456
author Kiyotaka Tokuraku
Meg Marquardt
Tsuneya Ikezu
author_facet Kiyotaka Tokuraku
Meg Marquardt
Tsuneya Ikezu
author_sort Kiyotaka Tokuraku
collection DOAJ
description <h4>Background</h4>Protein aggregation plays a major role in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease. However, direct real-time imaging of protein aggregation, including oligomerization and fibrillization, has never been achieved. Here we demonstrate the preparation of fluorescent semiconductor nanocrystal (quantum dot; QD)-labeled amyloid-beta peptide (QDAbeta) and its advanced applications.<h4>Methodology/principal findings</h4>The QDAbeta construct retained Abeta oligomer-forming ability, and the sizes of these oligomers could be estimated from the relative fluorescence intensities of the imaged spots. Both QDAbeta coaggregation with intact Abeta42 and insertion into fibrils were detected by fluorescence microscopy. The coaggregation process was observed by real-time 3D imaging using slit-scanning confocal microscopy, which showed a typical sigmoid curve with 1.5 h in the lag-time and 12 h until saturation. Inhibition of coaggregation using an anti-Abeta antibody can be observed as 3D images on a microscopic scale. Microglia ingested monomeric QDAbeta more significantly than oligomeric QDAbeta, and the ingested QDAbeta was mainly accumulated in the lysosome.<h4>Conclusions/significance</h4>These data demonstrate that QDAbeta is a novel nanoprobe for studying Abeta oligomerization and fibrillization in multiple modalities and may be applicable for high-throughput drug screening systems.
format Article
id doaj-art-c24c9dae202f4a0da32608a4648cdd34
institution OA Journals
issn 1932-6203
language English
publishDate 2009-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c24c9dae202f4a0da32608a4648cdd342025-08-20T02:01:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-12-01412e849210.1371/journal.pone.0008492Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.Kiyotaka TokurakuMeg MarquardtTsuneya Ikezu<h4>Background</h4>Protein aggregation plays a major role in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease. However, direct real-time imaging of protein aggregation, including oligomerization and fibrillization, has never been achieved. Here we demonstrate the preparation of fluorescent semiconductor nanocrystal (quantum dot; QD)-labeled amyloid-beta peptide (QDAbeta) and its advanced applications.<h4>Methodology/principal findings</h4>The QDAbeta construct retained Abeta oligomer-forming ability, and the sizes of these oligomers could be estimated from the relative fluorescence intensities of the imaged spots. Both QDAbeta coaggregation with intact Abeta42 and insertion into fibrils were detected by fluorescence microscopy. The coaggregation process was observed by real-time 3D imaging using slit-scanning confocal microscopy, which showed a typical sigmoid curve with 1.5 h in the lag-time and 12 h until saturation. Inhibition of coaggregation using an anti-Abeta antibody can be observed as 3D images on a microscopic scale. Microglia ingested monomeric QDAbeta more significantly than oligomeric QDAbeta, and the ingested QDAbeta was mainly accumulated in the lysosome.<h4>Conclusions/significance</h4>These data demonstrate that QDAbeta is a novel nanoprobe for studying Abeta oligomerization and fibrillization in multiple modalities and may be applicable for high-throughput drug screening systems.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0008492&type=printable
spellingShingle Kiyotaka Tokuraku
Meg Marquardt
Tsuneya Ikezu
Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
PLoS ONE
title Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
title_full Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
title_fullStr Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
title_full_unstemmed Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
title_short Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
title_sort real time imaging and quantification of amyloid beta peptide aggregates by novel quantum dot nanoprobes
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0008492&type=printable
work_keys_str_mv AT kiyotakatokuraku realtimeimagingandquantificationofamyloidbetapeptideaggregatesbynovelquantumdotnanoprobes
AT megmarquardt realtimeimagingandquantificationofamyloidbetapeptideaggregatesbynovelquantumdotnanoprobes
AT tsuneyaikezu realtimeimagingandquantificationofamyloidbetapeptideaggregatesbynovelquantumdotnanoprobes